C07C 311/41
To an acyclic carbon atom of a hydrocarbon radical substituted by nitrogen
Official title: to an acyclic carbon atom of a hydrocarbon radical substituted by nitrogen atoms, not being part of nitro or nitroso groups
C07C311/41 (To an acyclic carbon atom of a hydrocarbon radical substituted by nitrogen) appears on 66 US grants and 50 published applications in this corpus.
Search patents in C07C- Granted patents
- 66
- Published applications
- 50
- Assignees
- 42
- Inventors
- 198
- Latest grant
- 17 Feb 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1992 | 2 | 0 |
| 1993 | 2 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 5 | 0 |
| 1999 | 2 | 0 |
| 2000 | 3 | 0 |
| 2001 | 3 | 0 |
| 2002 | 7 | 3 |
| 2003 | 4 | 1 |
| 2004 | 1 | 7 |
| 2005 | 3 | 1 |
| 2006 | 2 | 5 |
| 2007 | 1 | 3 |
| 2008 | 1 | 1 |
| 2009 | 2 | 1 |
| 2010 | 3 | 5 |
| 2011 | 6 | 2 |
| 2012 | 1 | 1 |
| 2013 | 3 | 3 |
| 2014 | 3 | 3 |
| 2015 | 2 | 2 |
| 2016 | 1 | 1 |
| 2017 | 1 | 2 |
| 2018 | 0 | 1 |
| 2019 | 1 | 0 |
| 2020 | 0 | 1 |
| 2021 | 1 | 1 |
| 2022 | 1 | 1 |
| 2023 | 0 | 3 |
| 2024 | 2 | 2 |
| 2025 | 0 | 0 |
| 2026 | 1 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods and compositions for targeting Tregs using CCR8 inhibitors17 Feb 2026US 12,552,753 B2Nanjing Immunophage Biomedical Co., Ltd.
- Selective ship inhibitors for treating disease9 Apr 2024US 11,952,328 B2The Research Foundation for The State University of New York
- Antibiotic ammonium compounds and methods for the treatment of bacterial infections9 Apr 2024US 11,952,330 B2Board of Regents, The University of Texas System
- 3-(benzylamino)-4-(cyclohexylamino)-n-(2-(piperazin-1-yl)ethyl)benzenesulfonamide derivatives and related ferrostatin-1 analogues as cell death inhibitors for treating e.g. stroke24 May 2022US 11,339,124 B2Universiteit Antwerpen
- UV cured benzophenone terminated quaternary ammonium antimicrobials for surfaces30 Mar 2021US 10,961,401 B2Nano Safe Coatings Incorporated
- Novel squaramide derivative and use thereof29 Aug 2024US 2024/0286994 A1Kosin University Industry-Academy Cooperation
- Novel squaramide derivative and use thereof8 Aug 2024US 2024/0261249 A1Kosin University Industry-Academy Cooperation
- Methods and Compositions for Targeting Tregs using CCR8 Inhibitors25 May 2023US 2023/0159446 A1Nanjing Immunophage Biomedical Co., Ltd.
- Nonlinear optical material, light absorbing material, recording medium, method for recording information, and method for reading out information23 Mar 2023US 2023/0088916 A1Panasonic Intellectual Property Management Co., Ltd.
- Methods and compositions for targeting Tregs using CCR8 inhibitors9 Feb 2023US 2023/0038589 A1Nanjing Immunophage Biotech Co., Ltd.
Most cited
By later US patents
- α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors56US 6,248,775 B1G. D. Searle & Co. · 2001
- .alpha.-and .beta.-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors43US 5,843,946 AG. D. Searle & Co. · 1998
- .alpha.- and .beta.-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors42US 6,060,476 AG. D. Searle & Co. · 2000
- .beta.-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors34US 5,744,481 AG. D. Searle & Co. · 1998
- .alpha.- and .beta.-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors27US 5,968,942 AG. D. Searle & Co. · 1999